On Monday, December 10, Linde stated that shareholders will be offered an extra €1.22 (US$1.39) to help complete a merger with US rival Praxair, raising a squeeze-out offer to €189.46 (US$215.12) per share.
The two industrial gases groups won US antitrust approval for their US$86 billion merger in October, clearing a major regulatory hurdle for creating an industry leader with revenues of about US$27 billion.
A court-appointed auditor had confirmed the improved offer was adequate, Linde stated.
The squeeze-out is still subject to a resolution at a shareholder meeting scheduled for Wednesday, December 12, Linde stated.
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Former Pioneer CEO Accused of Colluding With OPEC: FTC Refers Case for Potential Criminal Probe
May 2, 2024 by
CPI
South Korea’s Antitrust Regulator Greenlights K-Pop Powerhouse Deal
May 2, 2024 by
CPI
Exxon’s Pioneer Purchase Approved, Former CEO Barred from Board
May 2, 2024 by
CPI
Colorado Senate Rejects Bill Barring Rent-Setting Algorithms
May 2, 2024 by
CPI
Bayer Faces US Antitrust Suit Over Pet Meds Competition
May 2, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI